Figure 4From: Docking study of novel antihyperlipidemic thieno[2,3-d]pyrimidine; LM-1554, with some molecular targets related to hyperlipidemia - an investigation into its mechanism of action3D-docking of LM-1554 with the molecular target CRP. a. 3D-docking of LM-1554 into PDB structure of CRP. b. 3D-docking of native ligand, phosphocholine, into PDB structure of CRP.Back to article page